Antiviral response: 10 mg/kg · patients being treated for HIV infection
It is very uncertain whether PRO 140 changes antiviral response: 10 mg/kg compared with placebo (very low certainty).
1 finding from 1 review
Antiviral response ‐ 162 mg weekly · patients being treated for HIV infection
It is very uncertain whether PRO 140 changes antiviral response: 162 mg weekly compared with placebo (very low certainty).
1 finding from 1 review
Antiviral response ‐ 324 mg weekly · patients being treated for HIV infection
It is very uncertain whether PRO 140 changes antiviral response: 324 mg weekly compared with placebo (very low certainty).
1 finding from 1 review
Antiviral response ‐ 324 mg biweekly · patients being treated for HIV infection
It is very uncertain whether PRO 140 changes antiviral response: 324 mg biweekly compared with placebo (very low certainty).
1 finding from 1 review
Individual nadir changes in HIV‐1 RNA level ‐ 0.5mg/Kg · patients being treated for HIV infection
1 finding from 1 review
Individual nadir changes in HIV‐1 RNA level ‐ 2mg/Kg · patients being treated for HIV infection
1 finding from 1 review
All‐cause mortality · Kaposi sarcoma in children with HIV‐1 infection
It is very uncertain whether combination Chemotherapy + ART changes mortality compared with single Agent Chemotherapy + ART (very low certainty).
1 finding from 1 review
RR 0.38 [0.24, 0.58]
50 participants
Very low
Mean CD4% Increase During Chemo · Kaposi sarcoma in children with HIV‐1 infection
1 finding from 1 review
no estimate extracted
48 participants
Very low
All‐cause mortality · Kaposi sarcoma in children with HIV‐1 infection
It is very uncertain whether chemotherapy + ART changes mortality compared with ART (very low certainty).
1 finding from 1 review
RR 0.72 [0.37, 1.43]
50 participants
Very low
Complete response · Kaposi sarcoma in children with HIV‐1 infection
It is very uncertain whether chemotherapy + ART changes complete Response to Tx compared with chemotherapy Alone (very low certainty).
1 finding from 1 review
RR 6.54 [1, 42.86]
36 participants
Very low
Complete response plus partial response Length of · Kaposi sarcoma in children with HIV‐1 infection
It is very uncertain whether chemotherapy + ART changes complete/Partial Response to Tx compared with chemotherapy Alone (very low certainty).
1 finding from 1 review
RR 1.47 [0.87, 2.49]
36 participants
Very low
Complete Among Known Outcome · Kaposi sarcoma in children with HIV‐1 infection
It is very uncertain whether chemotherapy + ART changes complete Among Known Outcome compared with chemotherapy Alone (very low certainty).
1 finding from 1 review
RR 4.25 [0.7, 25.91]
30 participants
Very low
Complete/Partial Among Known Outcome · Kaposi sarcoma in children with HIV‐1 infection
It is very uncertain whether chemotherapy + ART changes complete/Partial Among Known Outcome compared with chemotherapy Alone (very low certainty).
1 finding from 1 review
RR 1.01 [0.81, 1.27]
30 participants
Very low
All‐cause mortality · Kaposi sarcoma in children with HIV‐1 infection
It is very uncertain whether chemotherapy + ART changes mortality compared with chemotherapy Alone (very low certainty).
1 finding from 1 review
RR 0.46 [0.29, 0.73]
98 participants
Very low
Complete: Vincristine+ART vs Bleomycin+vincristine+ART · Kaposi sarcoma in children with HIV‐1 infection
It is very uncertain whether vincristine + ART changes complete: Vincristine+ART vs Bleomycin+vincristine+ART compared with bleomycin + vincristine + ART (very low certainty).
1 finding from 1 review
RR 0.69 [0.33, 1.47]
26 participants
Very low
Complete/Partial: Vincristine+ART vs Bleomycin+vincristine+ART · Kaposi sarcoma in children with HIV‐1 infection
It is very uncertain whether vincristine + ART changes complete/Partial: Vincristine+ART vs Bleomycin+vincristine+ART compared with bleomycin + vincristine + ART (very low certainty).
1 finding from 1 review
RR 0.79 [0.52, 1.2]
26 participants
Very low
Complete response · Kaposi sarcoma in children with HIV‐1 infection
It is very uncertain whether ART alone changes complete Response compared with vincristine or Bleomycin (very low certainty).
1 finding from 1 review
RR 1.2 [0.13, 11.43]
24 participants
Very low
Brain tumour response rates: complete response (CR) and partial response (PR) combinedNo. of participants: 847(6 RCTs) · Kaposi sarcoma in children with HIV‐1 infection
It is very uncertain whether ART alone changes complete or Partial Response compared with vincristine or Bleomycin (very low certainty).
1 finding from 1 review
RR 0.2 [0.05, 0.79]
24 participants
Very low
Complete response · Kaposi sarcoma in children with HIV‐1 infection
It is very uncertain whether chemotherapy + ART changes complete Response to Tx compared with ART (very low certainty).
1 finding from 1 review
RR 1.57 [0.22, 11.34]
89 participants
Very low
Complete response plus partial response Length of · Kaposi sarcoma in children with HIV‐1 infection
It is very uncertain whether chemotherapy + ART changes complete/Partial Response to Tx compared with ART (very low certainty).
1 finding from 1 review
RR 5.75 [1.59, 20.73]
39 participants
Very low